Authors: Kerry Goldina, Bridget Brackney, Tessa Lutterman, Brandi N. Williamson, Manmeet Singh, Christopher Winsk, Kathleen Cordova, Meaghan Flagg, Emmie de Wit
Year: 2025
Journal: Antiviral Res
DOI: 10.1016/j.antiviral.2025.106263
Summary#
The study investigates the effect of dexamethasone on Nipah virus-infected Syrian hamsters, finding that while it reduces pulmonary pathology, it does not increase survival.
Key Findings#
- Dexamethasone treatment produces hematologic changes in uninfected animals in a dose-dependent manner.
- In NiV-infected animals, the anti-inflammatory dose of dexamethasone reduces pulmonary pathology, while the immunosuppressive dose has no effect.
- The anti-inflammatory dose does not increase virus replication in tissues or virus shedding from the respiratory tract.
- Despite reduced lung pathology, dexamethasone treatment does not increase survival after NiV challenge.
Methodology#
- Study Type: Experimental Study
- Sample Size: Syrian Hamsters
- Geographic Focus: Hamilton, MT, United States of America
Topics#
Virology, Treatment, Hamster Model
Relevance#
The study provides critical information on the effect of dexamethasone administration on the outcome of NiV infection.